Encision, Inc. earnings releases ECIA

Annual Quarterly

Encision, Inc. last reported quarterly results on Jul 15, 2024, for Q1 FY2025 (the quarter ended Jun 30, 2024): revenue of $1.6 million (-1.4% year over year) and diluted EPS of $0.00. It usually reports 15–45 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 15–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Jul 15, 2024 15 days after quarter end	Q1 FY2025 ended Jun 30, 2024	2 -1.4%	0 +115.7%	0.00 +100.0%
Feb 14, 2024 45 days after quarter end	Q3 FY2024 ended Dec 31, 2023	2 -6.1%	-0 +4.3%	-0.02 +0.0%
Nov 14, 2023 45 days after quarter end	— ended Sep 30, 2023	—	—	—
Aug 3, 2023 34 days after quarter end	— ended Jun 30, 2023	—	—	—
Feb 7, 2023 38 days after quarter end	— ended Dec 31, 2022	—	—	—
Nov 14, 2022 45 days after quarter end	— ended Sep 30, 2022	—	—	—
Aug 9, 2022 40 days after quarter end	— ended Jun 30, 2022	—	—	—
Feb 10, 2022 41 days after quarter end	— ended Dec 31, 2021	—	—	—

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ECIA (OTC)
Fiscal year ends: March 31
Incorporated in: CO
Headquarters: Boulder, CO
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 930775
Former names: ELECTROSCOPE INC (until Aug 1, 2000)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.